Puberty Blockers: FDA's Califf Asked If REMS, Boxed Warning Against Off-Label Use In The Works

 
• By Sue Sutter
Gender dysphoria
The FDA is being pressed on treatments used off-label for gender dysphoria. • Source: Shutterstock

More from Drug Safety

More from Pink Sheet